Xpos™
PosaconazoleAntifungals (Systemic Antifungal) Indication: Posaconazole is indicated in patients aged 13 years and above for the treatment of following fungal infections: -Invasive aspergillosis in patients with disease that is refractory or intolerant to Amphotericin B or ltraconazole -Fusariosis in patients with disease that is refractory or intolerant to Amphotericin B -Chromoblastomycosis and mycetoma in patients […]